Brain health - time matters: multiple sclerosis, neuromyelitis optica spectrum disorder (NMOSD), myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) and related conditions. 2024 report.

Date publication

avril 2025

Journal

Multiple sclerosis and related disorders

Auteurs

Membres identifiés du Cancéropôle Est :
Pr DE SEZE Jérôme

Tous les auteurs :
Butzkueven H, Arkelsten S, Comi G, Costello K, Devlin M, Drulovic J, Gray E, Haartsen J, Helme A, Hlavácová J, Kasilingam E, Liu Y, Mathew T, Reyes S, de Sèze J, Williams MJ, Giovannoni G

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/40578068

Résumé

Multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD) and myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) are lifelong neuroimmunological diseases that can severely affect many aspects of people's lives. This report expands on our 2015 policy report and includes information about practice standards, emerging science, socioeconomic data analysis and disease understanding, to identify policy recommendations.

Mots clés

Brain health, Health policy, Multiple sclerosis, Myelin oligodendrocyte glycoprotein antibody-associated disease, Neuromyelitis optica spectrum disorder

Référence

Mult Scler Relat Disord. 2025 04 19;101:106456